Clinical trial
Applying Novel Biomarkers to Identify MINOCA Rapidly and the Prognostic Value of Novel Biomarkers Among Patients With Acute Chest Pain: a Clinical Study
NCT04974320 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Applying Novel Biomarkers to Identify MINOCA Rapidly and the Prognostic Value of Novel Biomarkers Among Patients With Acute Chest Pain: a Clinical Study
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 5, 2021
- Completion date
- August 31, 2024
- Enrollment
- 2,616 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copeptin, grow stimulation expressed gene 2, identification, myocardial infarction with non-obstructive coronary arteries, prognosis